Clinical Nutrition Market Synopsis
Clinical Nutrition Market Size Was Valued at USD 30.13 Billion in 2023, and is Projected to Reach USD 48.49 Billion by 2032, Growing at a CAGR of 5.43% From 2024-2032.
Clinical nutrition (CN) is an environmental science that ensures a balanced dietary source, and maintenance of health (Sanchez et al., 2015). CN uses supplements composed of good basic micronutrients that are not part of the regular diet due to malnutrition or other dietary reasons in the prevention of diseases and good health. CN is an essential component of the clinical treatment of acute and chronic diseases. Acute and chronic diseases like anemia, bowel syndrome, cancer, CKD, CVD, gastrointestinal diseases, obesity, pulmonary diseases, thyroid diseases, stroke, and other cognitive diseases (Sanchez et al., 2015), significantly affect the food intake and its metabolism leading to associated morbidity.
The awareness about the role of nutrition in health, can only transpire if a person properly focuses on its nutrition and is aware of the effects the nutrition has in their lives. Besides awareness, the significant part to understand regarding nutrition is about beneficial nutrients, that may be person-specific. Nutrients are the substances derived from food after digestion, used as a source of energy, structural components of different organic compounds, involved in the growth and repair of the tissues, organs, and body, and responsible for protecting the body from diseases.
Clinical Nutrition Market Trend Analysis
The Elderly Population, Chronic Illnesses, And Nutritional Science Advancements Promote Growth and Innovation.
- The clinical nutrition market is quickly changing because of trends such as a growing elderly population, increasing prevalence of chronic illnesses, and progress in nutritional science. This paves the way for growth and innovation in personalized nutrition.
- Progress in the field of nutrition science is centered on creating unique formulas for health conditions, modern delivery methods, and the significance of gut health, such as probiotics and the gut-brain connection, for overall well-being.
- The growth of home healthcare is leading to an increase in home-based nutrition, with clinical nutrition products being conveniently given at home. Incorporating telehealth enables the monitoring and adjusting of nutrition plans. Authorities are backing nutritional recommendations and regulations in response to the increasing desire for sustainable and plant-derived food options.
Genetics, Biomarkers, AI, And Big Data Enhance Individualized Nutrition for Patients.
- EXploring new markets in regions such as Asia-Pacific, Latin America, and Africa provides chances for growth. Utilizing genetics, biomarkers, AI, and big data for individualized nutrition can lead to better results for patients.
- In the field of clinical nutrition, there is potential for innovation in product development through the introduction of fresh formulations and delivery techniques. Fortified food and drinks have the potential to attract a wider range of consumers. Combining clinical nutrition with digital health tools such as health-tracking apps and telehealth services has the potential to enhance individualized nutrition care and improve patient outcomes, especially for individuals with chronic illnesses.
- Concentrate on preventative nutrition with clinical nutrition products in wellness programs and corporate initiatives to prevent disease. Focus on pediatric, maternal, sports, and active lifestyle nutrition for market growth due to increasing elderly populations and the prevalence of chronic illnesses.
Clinical Nutrition Market Segment Analysis:
Clinical Nutrition Market Segmented based on Product Type, Application, Route of Administration, End-User.
By Application, Cancer Is Expected to Dominate the Market During the Forecast Period
- Cancer holds a strong presence in the clinical nutrition market because of its high prevalence worldwide, as well as the long-term treatment requirements and cancer-induced malnutrition. Nutritional support is essential for the management of health, the response to treatment, and the overall outcomes of patients.
- Customized formulas address specific nutritional requirements of individuals with cancer, helping with recovery and minimizing side effects of treatment. Incorporating diverse clinical nutrition in cancer treatment for best support.
- Healthcare providers are starting to realize the significance of clinical nutrition in cancer treatment, resulting in proactive assistance with nutrition. Clinical guidelines stress the importance of early intervention. Research is dedicated to creating specific formulas and products for individuals with cancer. Dominating the market signifies strong demand and significant economic influence in controlling treatment expenses.
By Route of Administration, the Oral Segment Held the Largest Share
- The clinical nutrition industry depends on the oral route because of its ease of administration, patient adherence, and wide range of uses for various conditions. Its convenience, effectiveness, and status as the top choice for nutrition support make it the preferred option.
- Different needs are addressed by a range of oral nutritional products. These items can be easily found in both physical stores and on the internet, offering affordable choices that decrease the use of healthcare resources.
- The preferred method for administering nutritional supplements is through the mouth because it carries minimal complications, is easy to do, and is cost-efficient. It is becoming more and more common in households and among older individuals, resulting in improved quality of life and better management of long-term illnesses. It is anticipated that this trend will persist in the clinical nutrition market.
Clinical Nutrition Market Regional Insights:
Asia Pacific is expected to Dominate the Market Over the Forecast Period
- The Asia-Pacific region's clinical nutrition market is leading because of fast economic growth, urbanization causing lifestyle changes, a large and aging population with higher healthcare needs, and increasing recognition of nutrition's significance in managing health.
- The prevalence of chronic illnesses in Asia-Pacific is increasing, resulting in a higher demand for clinical nutrition products. Nutrient inadequacies continue, leading to government funding for healthcare and nutrition programs.
- Increased knowledge and education on nutrition and disease prevention in the Asia-Pacific region. Rising interest in clinical nutrition products fueled by health-conscious demographic. Growth of international and domestic businesses in the area. Increase in medical tourism for all-inclusive care options.
Clinical Nutrition Market Active Players
- Abbott Laboratories (USA)
- Nestlé Health Science (Switzerland)
- Danone Nutricia (France)
- BaXter International Inc. (USA)
- Fresenius Kabi (Germany)
- B. Braun Melsungen AG (Germany)
- Mead Johnson Nutrition (USA)
- Otsuka Pharmaceutical Co., Ltd. (Japan)
- Pfizer Inc. (USA)
- GlaXoSmithKline plc (UK)
- Nutricia Advanced Medical Nutrition (Netherlands)
- Perrigo Company plc (Ireland)
- Lonza Group (Switzerland)
- DSM Nutritional Products (Netherlands)
- H. J. Heinz Company (USA)
- Arla Foods Ingredients Group (Denmark)
- Ajinomoto Co., Inc. (Japan)
- Nestlé SA (Switzerland)
- Koninklijke DSM N.V. (Netherlands)
- Cargill, Incorporated (USA)
- BASF SE (Germany)
- Vitaflo International Ltd. (UK)
- Kerry Group plc (Ireland)
- Glanbia plc (Ireland)
- AbbVie Inc. (USA)
- Yili Group (China)
- WuXi AppTec Co., Ltd. (China)
- Clover Corporation (Australia)
- Hero Group (Switzerland)
- The Kraft Heinz Company (USA)
Key Industry Developments in the Clinical Nutrition Market:
- In May 2024, Danone acquired Functional Formularies, a provider of whole food tube feeding solutions in the U.S., from Swander Pace Capital. This acquisition is a strategic component of Danone's Renew Strategy, enhancing the company's Medical Nutrition offerings in the U.S. market by broadening its portfolio of enteral tube feeding products.
- In December 2023, Danone India launched new flavors of ProtineX, which are free from added sugar. This move is in line with Danone's commitment to FSSAI's Eat Right Movement, to reduce sugar in its products by 20% by 2020. The HFD brand ProtineX has been a trusted choice for Indian consumers for over six decades, and this new addition aims to provide healthier food options to its customers.
|
Clinical Nutrition Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2024: |
USD 30.13 Bn. |
|
Forecast Period 2024-32 CAGR: |
5.43 % |
Market Size in 2032: |
USD 48.49 Bn. |
|
Segments Covered: |
By Product Type |
|
|
|
By Application |
|
||
|
By Route of Administration |
|
||
|
By End-User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Clinical Nutrition Market by Product Type (2018-2032)
4.1 Clinical Nutrition Market Snapshot and Growth Engine
4.2 Market Overview
4.3 Enteral Nutrition
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
4.3.3 Key Market Trends, Growth Factors, and Opportunities
4.3.4 Geographic Segmentation Analysis
4.4 Parenteral Nutrition
4.5 Oral Nutritional Supplements (ONS)
Chapter 5: Clinical Nutrition Market by Application (2018-2032)
5.1 Clinical Nutrition Market Snapshot and Growth Engine
5.2 Market Overview
5.3 Cancer
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
5.3.3 Key Market Trends, Growth Factors, and Opportunities
5.3.4 Geographic Segmentation Analysis
5.4 Neurological Diseases
5.5 Gastrointestinal Disorders
5.6 Diabetes
5.7 Critical Care
5.8 Renal Diseases
5.9 Pediatric Malnutrition
Chapter 6: Clinical Nutrition Market by Route of Administration (2018-2032)
6.1 Clinical Nutrition Market Snapshot and Growth Engine
6.2 Market Overview
6.3 Oral
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
6.3.3 Key Market Trends, Growth Factors, and Opportunities
6.3.4 Geographic Segmentation Analysis
6.4 Enteral
6.5 Parenteral
Chapter 7: Clinical Nutrition Market by End-User (2018-2032)
7.1 Clinical Nutrition Market Snapshot and Growth Engine
7.2 Market Overview
7.3 Hospitals
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
7.3.3 Key Market Trends, Growth Factors, and Opportunities
7.3.4 Geographic Segmentation Analysis
7.4 Home Care Settings
7.5 Long-Term Care Facilities
7.6 Clinics
7.7 Ambulatory Surgical Centers (ASCs)
Chapter 8: Company Profiles and Competitive Analysis
8.1 Competitive Landscape
8.1.1 Competitive Benchmarking
8.1.2 Clinical Nutrition Market Share by Manufacturer (2024)
8.1.3 Industry BCG Matrix
8.1.4 Heat Map Analysis
8.1.5 Mergers and Acquisitions
8.2 ABBOTT LABORATORIES (USA)
8.2.1 Company Overview
8.2.2 Key Executives
8.2.3 Company Snapshot
8.2.4 Role of the Company in the Market
8.2.5 Sustainability and Social Responsibility
8.2.6 Operating Business Segments
8.2.7 Product Portfolio
8.2.8 Business Performance
8.2.9 Key Strategic Moves and Recent Developments
8.2.10 SWOT Analysis
8.3 NESTLÉ HEALTH SCIENCE (SWITZERLAND)
8.4 DANONE NUTRICIA (FRANCE)
8.5 BAXTER INTERNATIONAL INC. (USA)
8.6 FRESENIUS KABI (GERMANY)
8.7 B. BRAUN MELSUNGEN AG (GERMANY)
8.8 MEAD JOHNSON NUTRITION (USA)
8.9 OTSUKA PHARMACEUTICAL COLTD. (JAPAN)
8.10 PFIZER INC. (USA)
8.11 GLAXOSMITHKLINE PLC (UK)
8.12 NUTRICIA ADVANCED MEDICAL NUTRITION (NETHERLANDS)
8.13 PERRIGO COMPANY PLC (IRELAND)
8.14 LONZA GROUP (SWITZERLAND)
8.15 DSM NUTRITIONAL PRODUCTS (NETHERLANDS)
8.16 H. J. HEINZ COMPANY (USA)
8.17 ARLA FOODS INGREDIENTS GROUP (DENMARK)
8.18 AJINOMOTO COINC. (JAPAN)
8.19 NESTLÉ SA (SWITZERLAND)
8.20 KONINKLIJKE DSM N.V. (NETHERLANDS)
8.21 CARGILL INCORPORATED (USA)
8.22 BASF SE (GERMANY)
8.23 VITAFLO INTERNATIONAL LTD. (UK)
8.24 KERRY GROUP PLC (IRELAND)
8.25 GLANBIA PLC (IRELAND)
8.26 ABBVIE INC. (USA)
8.27 YILI GROUP (CHINA)
8.28 WUXI APPTEC COLTD. (CHINA)
8.29 CLOVER CORPORATION (AUSTRALIA)
8.30 HERO GROUP (SWITZERLAND)
8.31 THE KRAFT HEINZ COMPANY (USA)
Chapter 9: Global Clinical Nutrition Market By Region
9.1 Overview
9.2. North America Clinical Nutrition Market
9.2.1 Key Market Trends, Growth Factors and Opportunities
9.2.2 Top Key Companies
9.2.3 Historic and Forecasted Market Size by Segments
9.2.4 Historic and Forecasted Market Size by Product Type
9.2.4.1 Enteral Nutrition
9.2.4.2 Parenteral Nutrition
9.2.4.3 Oral Nutritional Supplements (ONS)
9.2.5 Historic and Forecasted Market Size by Application
9.2.5.1 Cancer
9.2.5.2 Neurological Diseases
9.2.5.3 Gastrointestinal Disorders
9.2.5.4 Diabetes
9.2.5.5 Critical Care
9.2.5.6 Renal Diseases
9.2.5.7 Pediatric Malnutrition
9.2.6 Historic and Forecasted Market Size by Route of Administration
9.2.6.1 Oral
9.2.6.2 Enteral
9.2.6.3 Parenteral
9.2.7 Historic and Forecasted Market Size by End-User
9.2.7.1 Hospitals
9.2.7.2 Home Care Settings
9.2.7.3 Long-Term Care Facilities
9.2.7.4 Clinics
9.2.7.5 Ambulatory Surgical Centers (ASCs)
9.2.8 Historic and Forecast Market Size by Country
9.2.8.1 US
9.2.8.2 Canada
9.2.8.3 Mexico
9.3. Eastern Europe Clinical Nutrition Market
9.3.1 Key Market Trends, Growth Factors and Opportunities
9.3.2 Top Key Companies
9.3.3 Historic and Forecasted Market Size by Segments
9.3.4 Historic and Forecasted Market Size by Product Type
9.3.4.1 Enteral Nutrition
9.3.4.2 Parenteral Nutrition
9.3.4.3 Oral Nutritional Supplements (ONS)
9.3.5 Historic and Forecasted Market Size by Application
9.3.5.1 Cancer
9.3.5.2 Neurological Diseases
9.3.5.3 Gastrointestinal Disorders
9.3.5.4 Diabetes
9.3.5.5 Critical Care
9.3.5.6 Renal Diseases
9.3.5.7 Pediatric Malnutrition
9.3.6 Historic and Forecasted Market Size by Route of Administration
9.3.6.1 Oral
9.3.6.2 Enteral
9.3.6.3 Parenteral
9.3.7 Historic and Forecasted Market Size by End-User
9.3.7.1 Hospitals
9.3.7.2 Home Care Settings
9.3.7.3 Long-Term Care Facilities
9.3.7.4 Clinics
9.3.7.5 Ambulatory Surgical Centers (ASCs)
9.3.8 Historic and Forecast Market Size by Country
9.3.8.1 Russia
9.3.8.2 Bulgaria
9.3.8.3 The Czech Republic
9.3.8.4 Hungary
9.3.8.5 Poland
9.3.8.6 Romania
9.3.8.7 Rest of Eastern Europe
9.4. Western Europe Clinical Nutrition Market
9.4.1 Key Market Trends, Growth Factors and Opportunities
9.4.2 Top Key Companies
9.4.3 Historic and Forecasted Market Size by Segments
9.4.4 Historic and Forecasted Market Size by Product Type
9.4.4.1 Enteral Nutrition
9.4.4.2 Parenteral Nutrition
9.4.4.3 Oral Nutritional Supplements (ONS)
9.4.5 Historic and Forecasted Market Size by Application
9.4.5.1 Cancer
9.4.5.2 Neurological Diseases
9.4.5.3 Gastrointestinal Disorders
9.4.5.4 Diabetes
9.4.5.5 Critical Care
9.4.5.6 Renal Diseases
9.4.5.7 Pediatric Malnutrition
9.4.6 Historic and Forecasted Market Size by Route of Administration
9.4.6.1 Oral
9.4.6.2 Enteral
9.4.6.3 Parenteral
9.4.7 Historic and Forecasted Market Size by End-User
9.4.7.1 Hospitals
9.4.7.2 Home Care Settings
9.4.7.3 Long-Term Care Facilities
9.4.7.4 Clinics
9.4.7.5 Ambulatory Surgical Centers (ASCs)
9.4.8 Historic and Forecast Market Size by Country
9.4.8.1 Germany
9.4.8.2 UK
9.4.8.3 France
9.4.8.4 The Netherlands
9.4.8.5 Italy
9.4.8.6 Spain
9.4.8.7 Rest of Western Europe
9.5. Asia Pacific Clinical Nutrition Market
9.5.1 Key Market Trends, Growth Factors and Opportunities
9.5.2 Top Key Companies
9.5.3 Historic and Forecasted Market Size by Segments
9.5.4 Historic and Forecasted Market Size by Product Type
9.5.4.1 Enteral Nutrition
9.5.4.2 Parenteral Nutrition
9.5.4.3 Oral Nutritional Supplements (ONS)
9.5.5 Historic and Forecasted Market Size by Application
9.5.5.1 Cancer
9.5.5.2 Neurological Diseases
9.5.5.3 Gastrointestinal Disorders
9.5.5.4 Diabetes
9.5.5.5 Critical Care
9.5.5.6 Renal Diseases
9.5.5.7 Pediatric Malnutrition
9.5.6 Historic and Forecasted Market Size by Route of Administration
9.5.6.1 Oral
9.5.6.2 Enteral
9.5.6.3 Parenteral
9.5.7 Historic and Forecasted Market Size by End-User
9.5.7.1 Hospitals
9.5.7.2 Home Care Settings
9.5.7.3 Long-Term Care Facilities
9.5.7.4 Clinics
9.5.7.5 Ambulatory Surgical Centers (ASCs)
9.5.8 Historic and Forecast Market Size by Country
9.5.8.1 China
9.5.8.2 India
9.5.8.3 Japan
9.5.8.4 South Korea
9.5.8.5 Malaysia
9.5.8.6 Thailand
9.5.8.7 Vietnam
9.5.8.8 The Philippines
9.5.8.9 Australia
9.5.8.10 New Zealand
9.5.8.11 Rest of APAC
9.6. Middle East & Africa Clinical Nutrition Market
9.6.1 Key Market Trends, Growth Factors and Opportunities
9.6.2 Top Key Companies
9.6.3 Historic and Forecasted Market Size by Segments
9.6.4 Historic and Forecasted Market Size by Product Type
9.6.4.1 Enteral Nutrition
9.6.4.2 Parenteral Nutrition
9.6.4.3 Oral Nutritional Supplements (ONS)
9.6.5 Historic and Forecasted Market Size by Application
9.6.5.1 Cancer
9.6.5.2 Neurological Diseases
9.6.5.3 Gastrointestinal Disorders
9.6.5.4 Diabetes
9.6.5.5 Critical Care
9.6.5.6 Renal Diseases
9.6.5.7 Pediatric Malnutrition
9.6.6 Historic and Forecasted Market Size by Route of Administration
9.6.6.1 Oral
9.6.6.2 Enteral
9.6.6.3 Parenteral
9.6.7 Historic and Forecasted Market Size by End-User
9.6.7.1 Hospitals
9.6.7.2 Home Care Settings
9.6.7.3 Long-Term Care Facilities
9.6.7.4 Clinics
9.6.7.5 Ambulatory Surgical Centers (ASCs)
9.6.8 Historic and Forecast Market Size by Country
9.6.8.1 Turkiye
9.6.8.2 Bahrain
9.6.8.3 Kuwait
9.6.8.4 Saudi Arabia
9.6.8.5 Qatar
9.6.8.6 UAE
9.6.8.7 Israel
9.6.8.8 South Africa
9.7. South America Clinical Nutrition Market
9.7.1 Key Market Trends, Growth Factors and Opportunities
9.7.2 Top Key Companies
9.7.3 Historic and Forecasted Market Size by Segments
9.7.4 Historic and Forecasted Market Size by Product Type
9.7.4.1 Enteral Nutrition
9.7.4.2 Parenteral Nutrition
9.7.4.3 Oral Nutritional Supplements (ONS)
9.7.5 Historic and Forecasted Market Size by Application
9.7.5.1 Cancer
9.7.5.2 Neurological Diseases
9.7.5.3 Gastrointestinal Disorders
9.7.5.4 Diabetes
9.7.5.5 Critical Care
9.7.5.6 Renal Diseases
9.7.5.7 Pediatric Malnutrition
9.7.6 Historic and Forecasted Market Size by Route of Administration
9.7.6.1 Oral
9.7.6.2 Enteral
9.7.6.3 Parenteral
9.7.7 Historic and Forecasted Market Size by End-User
9.7.7.1 Hospitals
9.7.7.2 Home Care Settings
9.7.7.3 Long-Term Care Facilities
9.7.7.4 Clinics
9.7.7.5 Ambulatory Surgical Centers (ASCs)
9.7.8 Historic and Forecast Market Size by Country
9.7.8.1 Brazil
9.7.8.2 Argentina
9.7.8.3 Rest of SA
Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies
Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research
|
Clinical Nutrition Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2024: |
USD 30.13 Bn. |
|
Forecast Period 2024-32 CAGR: |
5.43 % |
Market Size in 2032: |
USD 48.49 Bn. |
|
Segments Covered: |
By Product Type |
|
|
|
By Application |
|
||
|
By Route of Administration |
|
||
|
By End-User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
